Back to search

Article

<i>N</i> -arylpyrazole NOD2 agonists promote immune checkpoint inhibitor therapy

2023-01-27

Abstract excerpt

<h4>ABSTRACT</h4> The characterization of microbiota mechanisms in health and disease has reinvigorated pattern recognition receptors as prominent targets for immunotherapy. Notably, our recent studies on Enterococcus species revealed peptidoglycan remodeling and activation of NOD2 as key mechanisms for microbiota enhancement of immune checkpoint inhibitor therapy. Inspired by this work and other studies of NOD2...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
71bd9bec-cf6f-59c8-830d-c162cca5391c
DOI
10.1101/2023.01.26.525573
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<i>N</i> -arylpyrazole NOD2 agonists promote immune checkpoint inhibitor therapyDOI 10.1101/2023.01.26.525573
Select a neighboring publication to make it the new centre.